AMRN
Price
$0.45
Change
-$0.00 (-0.00%)
Updated
Apr 1, 02:28 PM (EDT)
Capitalization
357.53M
29 days until earnings call
HRTX
Price
$2.14
Change
-$0.06 (-2.73%)
Updated
Apr 1, 02:41 PM (EDT)
Capitalization
344.26M
41 days until earnings call
Ad is loading...

AMRN vs HRTX

Header iconAMRN vs HRTX Comparison
Open Charts AMRN vs HRTXBanner chart's image
Amarin
Price$0.45
Change-$0.00 (-0.00%)
Volume$100
Capitalization357.53M
Heron Therapeutics
Price$2.14
Change-$0.06 (-2.73%)
Volume$340
Capitalization344.26M
AMRN vs HRTX Comparison Chart
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. HRTX commentary
Apr 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and HRTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 01, 2025
Stock price -- (AMRN: $0.45 vs. HRTX: $2.20)
Brand notoriety: AMRN: Notable vs. HRTX: Not notable
AMRN represents the Pharmaceuticals: Major, while HRTX is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 69% vs. HRTX: 67%
Market capitalization -- AMRN: $357.53M vs. HRTX: $344.26M
AMRN [@Pharmaceuticals: Major] is valued at $357.53M. HRTX’s [@Biotechnology] market capitalization is $344.26M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $304.59B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileHRTX’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • HRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, HRTX is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 5 TA indicator(s) are bullish while HRTX’s TA Score has 4 bullish TA indicator(s).

  • AMRN’s TA Score: 5 bullish, 5 bearish.
  • HRTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMRN and HRTX are a good buy in the short-term.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а -3.53% price change this week, while HRTX (@Biotechnology) price change was -9.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.53%. For the same industry, the average monthly price growth was -0.90%, and the average quarterly price growth was -6.46%.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.99%. For the same industry, the average monthly price growth was -12.25%, and the average quarterly price growth was -11.15%.

Reported Earning Dates

AMRN is expected to report earnings on Apr 30, 2025.

HRTX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.53% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (-7.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRN($358M) and HRTX($344M) have the same market capitalization . HRTX YTD gains are higher at: 43.791 vs. AMRN (-7.608). HRTX has higher annual earnings (EBITDA): -5.06M vs. AMRN (-50.7M). AMRN has more cash in the bank: 321M vs. HRTX (59.3M). AMRN has less debt than HRTX: AMRN (8.74M) vs HRTX (178M). AMRN has higher revenues than HRTX: AMRN (307M) vs HRTX (144M).
AMRNHRTXAMRN / HRTX
Capitalization358M344M104%
EBITDA-50.7M-5.06M1,003%
Gain YTD-7.60843.791-17%
P/E Ratio67.11N/A-
Revenue307M144M213%
Total Cash321M59.3M541%
Total Debt8.74M178M5%
FUNDAMENTALS RATINGS
AMRN vs HRTX: Fundamental Ratings
AMRN
HRTX
OUTLOOK RATING
1..100
1076
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
8638
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HRTX's Valuation (70) in the Biotechnology industry is in the same range as AMRN (87) in the Pharmaceuticals Other industry. This means that HRTX’s stock grew similarly to AMRN’s over the last 12 months.

HRTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that HRTX’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as HRTX (100) in the Biotechnology industry. This means that AMRN’s stock grew similarly to HRTX’s over the last 12 months.

HRTX's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for AMRN (86) in the Pharmaceuticals Other industry. This means that HRTX’s stock grew somewhat faster than AMRN’s over the last 12 months.

HRTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that HRTX’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNHRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 15 days ago
84%
Declines
ODDS (%)
Bearish Trend 23 days ago
88%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MITIX33.120.17
+0.52%
MFS Massachusetts Investors Tr I
GBCIX17.10N/A
N/A
Gabelli Dividend Growth I
CUURX49.81N/A
N/A
Columbia Small Cap Value I Inst2
MSERX8.47N/A
N/A
MassMutual Small Cap Growth Eq R4
MGINX10.32N/A
N/A
DWS Global Macro Inst

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
+1.79%
KZR - AMRN
56%
Loosely correlated
-0.81%
CNTB - AMRN
55%
Loosely correlated
-19.12%
HRTX - AMRN
44%
Loosely correlated
-2.65%
MGNX - AMRN
44%
Loosely correlated
+0.79%
ALXO - AMRN
43%
Loosely correlated
-4.90%
More

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with GSGTF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-2.65%
GSGTF - HRTX
45%
Loosely correlated
N/A
AMRN - HRTX
44%
Loosely correlated
+1.79%
ACAD - HRTX
42%
Loosely correlated
-2.69%
ABOS - HRTX
39%
Loosely correlated
-7.56%
AXON - HRTX
38%
Loosely correlated
-1.68%
More